Source: Public Filings
ENTITY
SK Biopharmaceuticals (326030 KS)
SK Biopharmaceuticals (326030 KS)
114
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
x